Work from our group and others has demonstrated that CD69 is a key regulator of T cell responses, including the balance between proinflammatory Th17 cells and Tregs, which are crucial in the pathogenesis of CVDs such as myocarditis, MI, and atherosclerosis. This evidence concerns the gene CD69 and atherosclerosis.